By Daniella Parra Apollo Funds said it will acquire a majority stake in OEG Energy Group, an offshore energy services provider, from Oaktree Capital Management and other investors in a deal valued at over $1 billion. Vinson & Elkins advised...

By Karen Roman Sportradar Group AG (Nasdaq: SRAD) said it will acquire IMG ARENA’s global portfolio of sports betting rights by the fourth quarter, adding depth to its coverage of tennis, basketball and soccer. The company said the acquisition will...

By Karen Roman Waldencast plc (Nasdaq: WALD) said fourth quarter net revenue grew 30.8% to $72.1 million. Adjusted EBITDA doubled from the year prior to $11.2 million, or 15.5% of net revenue, driven by top-line performance and operational leverage, the...

By Daniella Parra Taiho Pharmaceutical said it will acquire Araris Biotech, a leader in antibody drug conjugates (ADCs), for an initial $400 million, with potential additional milestone payments of up to $740 million. Araris’ AraLinQ platform enhances ADC drug design,...

By Exec Edge Editorial Staff The fast-growing sector of iGaming has its share of success stories, but few can match the rocket-like trajectory of SPRIBE under David Natroshvili’s leadership. We sat down with the founder and CEO to discuss SPRIBE’s...

By Exec Edge Editorial Staff As the CEO of Hometown, a leading digital platform for K-12 schools and universities, Nick Mirisis has transformed what began as a ticketing service into a comprehensive solution for educational institutions across the United States....

By Jarrett Banks AirSculpt, which provides body contouring procedures, said it was implementing an operating plan after a challenging 2024. “We are developing the right operating plan and implementing the right actions to improve our platform and progress toward positive...

By Karen Roman HF Foods Group Inc. (Nasdaq: HFFG) said fourth quarter net revenue increased 8.7% to $305.3 million compared to $280.9 million in the year prior. Quarterly adjusted EBITDA rose 39.4% to $14.5 million in comparison to $10.4 million,...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced it finished the placement of NPM-115, its GLP-1 (exenatide) implant, in the first-in-human clinical trial of its kind. The company also said it achieved full enrollment for this study, which targets...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said it expects to spin off Cortigent, Inc., its brain implant devices division, as an independent publicly-traded company. Vivani aims to create two companies focused on driving long term value creation in...